Trials / Completed
CompletedNCT00915187
Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly
A Phase II Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly, a Double-blind Randomized, Controlled Single Center Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- NasVax Ltd · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
To examine the safety and immunogenicity of two formulation of liposomal adjuvant / delivery system (VaxiSomeTM=CCS-Cholesterol \[CCS/C\]), combined with commercial influenza vaccine in an elderly healthy population when given once intramuscularly (IM).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CCS/C | Adjuvant to influenza vaccine |
| BIOLOGICAL | Influenza Vaccine | Influenza vaccine |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2009-12-01
- Completion
- 2010-02-01
- First posted
- 2009-06-05
- Last updated
- 2011-10-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00915187. Inclusion in this directory is not an endorsement.